<DOC>
	<DOCNO>NCT01253421</DOCNO>
	<brief_summary>The purpose study evaluate effect single low dose D2/D3 antagonist amisulpride reward process . More generally , study test role dopamine ( naturally occur brain chemical ) depression . Hypotheses : Administration single low dose D2/D3 antagonist amisulpride ( 1 ) improve performance behavioral task assess learn feedback ( 2 ) boost activation reward-related brain region .</brief_summary>
	<brief_title>The Effects Dopamine Reward Processing</brief_title>
	<detailed_description>Through integration fMRI approach couple pharmacological challenge , goal current study investigate role dopamine MDD . Participants research include 36 MDD subject 36 demographically match healthy participant recruit community Dr. Pizzagalli 's laboratory McLean Hospital 's Center Depression , Anxiety Stress Research . This study include two session : - The first session involve diagnostic interview , series questionnaire assessment . - The second session take place McLean Hospital 's Neuroimaging Center , include administration low-dose amisulpride ( 50 mg capsule ) placebo , follow fMRI brain scan administration two behavioral task .</detailed_description>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Dopamine</mesh_term>
	<mesh_term>Sultopride</mesh_term>
	<mesh_term>Sulpiride</mesh_term>
	<criteria>Inclusion Criteria MDD Subjects : 1 . Diagnostic Statistical Manual Mental Disorders ( DSM IV ) diagnostic criterion MDD , diagnose use Structured Clinical Interview DSM Disorders ( SCID ) ; 2 . Written informed consent ; 3 . Both gender ethnic origin , age 18 45 ; 4 . A baseline HRSD score &gt; 16 ( 17item version ) ; 5 . Righthanded . 6 . Absence psychotropic medication least 2 week : 6 week fluoxetine , 6 month neuroleptic , 2 week benzodiazepine , 2 week antidepressant . Inclusion Criteria Control Subjects : 1 . Absence medical , neurological , psychiatric illness ( include alcohol substance abuse ) , assess subject history structure clinical interview ( SCIDI/NP ) ; 2 . Written informed consent ; 3 . Both gender ethnic origin , age 18 45 ; 4 . Righthanded ; 5 . Absence medication least 3 week ; 6 . Absence pregnancy . Exclusion Criteria All Subjects : 1 . Subjects suicidal ideation outpatient treatment determine unsafe study clinician . These patient immediately refer appropriate clinical treatment ; 2 . Pregnant woman woman childbearing potential use medically accept mean contraception ( defined oral contraceptive pill implant , condom , diaphragm , spermicide , IUD , s/p tubal ligation , partner vasectomy ) ; 3 . Serious unstable medical illness , include cardiovascular , hepatic , renal , respiratory , endocrine , neurological hematologic disease ; 4 . Lifetime history seizure disorder ; 5 . Lifetime history current diagnosis follow DSMIV psychiatric illness : organic mental disorder , schizophrenia , schizoaffective disorder , delusional disorder , psychotic disorder otherwise specify , bipolar disorder , patient mood congruent mood incongruent psychotic feature , substance dependence , substance abuse within last 12 month ( exception alcohol abuse within last 12 month , permissible MDD subject ) ; eat disorder , posttraumatic stress disorder ( lifetime PTSD exclusionary control subject , PTSD within last 24 month exclusionary MDD subject ) ; simple phobia , social anxiety disorder generalize anxiety disorder allow secondary MDD ; 6 . More five instance lifetime cocaine stimulant use ( e.g. , amphetamine , cocaine , methamphetamine ) ; 7 . Use dopaminergic drug ( include methylphenidate ) within last 6 month ; 8 . Lifetime history current diagnosis dementia , score &lt; 26 Mini Mental Status Examination screen visit ; 9 . Lifetime history adverse drug reaction allergy study drug ( amisulpride ) ; 10 . Patients mood congruent mood incongruent psychotic feature ; 11 . Current use psychotropic drug ; 12 . Clinical laboratory evidence hypothyroidism ; 13 . Patients lifetime history electroconvulsive therapy ( ECT ) ; 14 . Patients renal insufficiency ; 15 . Failure meet standard MRI safety requirement 16 . Electrolytes , BUN , Creatinine : outside normal range ( also rule renal insufficiency ) ; 17 . Liver function test ( SGOT , SGPT , CPK , alkaline phosphatase , total bilirubin ) 1.5X upper normal ; 18 . QTc interval EKG 450 m EKG indicative arrhythmia cardiac conduction abnormality ; 19 . Diabetes poor glucose control ; 20 . Cardiac disease , bradycardia le 55 bpm , hypokalemia , congenital prolongation QT interval ongoing treatment medication likely induce one condition . 21 . Currently cognitivebehavioral therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>MDD</keyword>
	<keyword>Major Depressive Disorder</keyword>
	<keyword>Amisulpride</keyword>
</DOC>